Back to results
US 2008/0167320 A1Published application
Novel arylpiperazine derivatives
OwnerMarc Capet, Denis Danvy +7inventors
InventorsMarc Capet, Denis Danvy, Nicolas Levoin, Marcel Morvan, Isabelle Berrebi-Bertrand, Thierry Calmels, Philippe Robert, Jean-Charles Schwartz, Jeanne-Marie Lecomte
Life of this patent
Estimating the term…
Abstract
Compounds of the general formula (I) below: are provided along with a process for preparing them, and these compounds may be used as therapeutic agents, e.g., for prevention and/or treatment of a neuropsychiatric illness or any illness involving the dopamine D3 receptor.
Claims22
Compounds of the formula (I):
- in which:
- R1 represents a heteroaryl with five or six chain links, containing one or more heteroatoms, selected from among 2-pyridyl, 2-pyrimidinyl, 2-pyridazinyl, 2-pyrazinyl, 2-imidazolyl, 2-oxazolyl, 2-thiazolyl, 3-isoxazolyl, 3-isothiazolyl, 1,2,4-triazol-2-yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl, optionally substituted, in addition to its two attachments, by one or more identical or different groups selected from among a halogen atom or a hydroxy, alkyl, monofluoroalkyl, polyfluoroalkyl, alkoxy, polyfluoroalkoxy, alkylsulfanyl, polyfluoroalkylsulfanyl group;
- Ar is an aryl or heteroaryl fused with R1 and optionally substituted by one or more identical or different substituents selected from among a halogen atom or alkyl, monofluoroalkyl, polyfluoroalkyl, alkoxy, polyfluoroalkoxy, alkylsulfanyl, polyfluoroalkylsulfanyl, cyano, carbamoyl, dialkylcarbamoyl, alkyl-C(═O)—, alkyl-O—C(═O)—, HO—C(═O)—, (HO)alkyl group;
- a=2, 3 or 4;
- b and c, identical or different, represent 1 or 2;
- R2, R3, R4, R5 and R6 each independently represent a hydrogen or halogen atom or a hydroxy, alkyl, monofluoroalkyl, polyfluoroalkyl, alkoxy, polyfluoroalkoxy, alkylsulfanyl, polyfluoroalkylsulfanyl, cyano, —NRR′, —COOR, —COR, —CONRR′ group or alternatively two adjacent R2, R3, R4, R5 and R6 are joined to one another to form a hydrocarbon cycle or a saturated or unsaturated heterocycle, fused to the phenyl nucleus to which they are attached;
- where R, R′, identical or different, independently represent a hydrogen atom, or an alkyl group;
- together with stereoisomers or mixtures thereof, the tautomeric forms thereof, the pharmaceutically acceptable salts thereof,
- with the exception of those compounds for which:
- R1 represents a 2-oxazolyl, 2-imidazolyl or 2-thiazolyl fused to the Ar group=optionally substituted phenyl,
- and compounds for which:
- R1 represents a 2-pyridyl group, fused to the Ar group=phenyl optionally substituted by Me in position 4 of the resultant quinoline cycle, a=2, b=c=1, R2=H, OMe and R3—R6=H or R2=R3=Me and R4—R6=H;
- R1 represents a 2-pyrimidinyl group, fused to the Ar group=phenyl substituted by OMe in positions 6 and 7 and —OH in position 4 or 6 of the resultant quinazolinyl cycle, a=2, b=c=1, R2=R3=R4=R5=H and R6=OMe.
10 more elements
Use of a compound of the general formula (I):
- in which:
- R1 represents a heteroaryl with five or six chain links, containing one or more heteroatoms, selected from among 2-pyridyl, 2-pyrimidinyl, 2-pyridazinyl, 2-pyrazinyl, 2-imidazolyl, 2-oxazolyl, 2-thiazolyl, 3-isoxazolyl, 3-isothiazolyl, 1,2,4-triazol-2-yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl, optionally substituted, in addition to its two attachments, by one or more identical or different groups selected from among a halogen atom or a hydroxy, alkyl, monofluoroalkyl, polyfluoroalkyl, alkoxy, polyfluoroalkoxy, alkylsulfanyl, polyfluoroalkylsulfanyl group;
- Ar is an aryl or heteroaryl fused with R1 and optionally substituted by one or more identical or different substituents selected from among a halogen atom or a hydroxy, alkyl, monofluoroalkyl, polyfluoroalkyl, alkoxy, polyfluoroalkoxy, alkylsulfanyl, polyfluoroalkylsulfanyl, cyano, carbamoyl, dialkylcarbamoyl, alkylC(═O)—, alkyl-O—C(═O)—, HO—C(═O)—, (HO)alkyl group, or Ar is an aryl or heteroaryl fused with a saturated, unsaturated or aromatic hydrocarbon cycle or heterocycle;
- a=2, 3 or 4;
- b and c, identical or different, represent 1 or 2;
- R2, R3, R4, R5 and R6 each independently represent a hydrogen or halogen atom or a hydroxy, alkyl, monofluoroalkyl, polyfluoroalkyl, alkoxy, polyfluoroalkoxy, alkylsulfanyl, polyfluoroalkylsulfanyl, cyano, —NRR′, —COOR, —COR, —CONRR′ group or alternatively two adjacent R2, R3, R4, R5 and R6 are joined to one another to form a hydrocarbon cycle or a saturated or unsaturated heterocycle, fused to the phenyl nucleus to which they are attached;
- where R, R′, identical or different, independently represent a hydrogen atom, or an alkyl group;
- together with stereoisomers or mixtures thereof, the tautomeric forms thereof, the pharmaceutically acceptable salts thereof,
- with the exception of those compounds for which:
- R1 represents a 2-pyridyl group, fused to the group Ar=phenyl, a=2, b=c=1, R2=H, OMe and R3—R6=H or R2=R3=Me and R4—R6=H,
- for the preparation of pharmaceutical compositions intended to act as a ligand for the dopamine D3 receptor.
8 more elements
Dependencies are inferred from the claim text.